Advertisement
Screener

Eagle Pharmaceuticals, Inc. Form DEF 14A: Definitive proxy statement

Eagle Pharmaceuticals, Inc. Form DEF 14A: Definitive proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2023-05-01: Form DEF 14A; Description DEF 14A; Document tm2314210d2_def14a.htm.
  • 2022-06-15: Form DEF 14A; Period of report 2022-07-28; Description DEF 14A; Document tm2218378-1_def14a.htm.
  • 2021-04-30: Form DEF 14A; Period of report 2021-07-13; Description DEF 14A; Document tm212442-1_def14a.htm.
  • 2020-04-29: Form DEF 14A; Period of report 2020-06-23; Description DEF 14A; Document a2241499zdef14a.htm.
FiledFormPeriod of reportDescriptionDocument
2023-05-01DEF 14ADEF 14Atm2314210d2_def14a.htm
2022-06-15DEF 14A2022-07-28DEF 14Atm2218378-1_def14a.htm
2021-04-30DEF 14A2021-07-13DEF 14Atm212442-1_def14a.htm
2020-04-29DEF 14A2020-06-23DEF 14Aa2241499zdef14a.htm
2019-04-30DEF 14A2019-06-18DEF 14Aa2238676zdef14a.htm
2018-04-30DEF 14A2018-06-19DEF 14Aa2235484zdef14a.htm
2017-04-28DEF 14A2017-06-20DEF 14Aa2232014zdef14a.htm
2016-07-12DEF 14A2016-08-02DEF 14Aa2229155zdef14a.htm
2015-06-25DEF 14A2015-08-04DEF 14Aa2225242zdef14a.htm